History of vitamin d treatment of renal osteodystrophy

American Journal of Nephrology

Volumn 17, Issue 3-4, 1997, Pages 382-386

  Morii, Hirotoshi ^a   Ishimura, Eiji ^a   Inoue, Takashi ^b   Tabata, Tsutomu ^b   Morita, Atsuko ^b   Nishii, Yasuho ^c   Fukushima, Masafumi ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1,25 Dihydroxycholecalciferol; 1 Hydroxycholecalciferol; Nephritogenoside nephritis; Parathyroid hormone; Renal osteodystrophy

Indexed keywords

22 OXACALCITRIOL; ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ION; COLECALCIFEROL; ERGOCALCIFEROL; FALECALCITRIOL; PHOSPHATE; VITAMIN D;

ALKALINE PHOSPHATASE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DRUG MEGADOSE; HEMODIALYSIS; HISTORY OF MEDICINE; HUMAN; PATIENT MONITORING; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; RENAL OSTEODYSTROPHY; VITAMIN D;

EID: 0030946986     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169125     Document Type: Article

References (20)

1. Lathrop FW: Renal dwarfism: Report of a case. Arch Intern Med 1926:38:612-622.
2. Langmead FS, Orr JW: Renal rickets associated with parathyroid hyperplasia. Arch Dis Child 1933:8:265-278.
3. Albright F, Drake TG, Sulkowitch HW: Renal osteitis fibrosa cystica: Report of a case with dissection of metabolic aspects. Bull Johns Hopkins Hosp 1937;60:377-399.
4. Liu SH, Chu HI: Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (AT-100) and iron. Medicine 1943;2:103-161.
5. Albright F, Reifenslein EC Jr: The Parathyroid Glands and Metabolic Bone Disease: Selected Studies. Baltimore. Williams & Wilkins. 1948. pp 115-121.
6. Fourman P, Royer P, Level MJ: Calcium Metabolism and the Bone, ed 2. Oxford. Blackwell. 1968. pp 415-430.
7. Morgan B: Osteomalacia. Renal Osteodystrophy and Osteoporosis. Springfield, Thomas. 1973. pp 224-231.
8. Adams ND, Raisz LG: Calcium regulation and bone metabolism and renal disease: in Martin TJ. Raisz LG (eds): Clinical Endocrinology of Calcium Metabolism. New York. Dekker. 1987. pp 317-367.
9. Koenig KG, Lindberg JS, Zcrwckh JF, Padalino PK, Cushner HM, Copley JB: Free and total 1.25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 1992:41:161-165.
10. Deluca H: A collaborative effort of basic science and clinical medicine. Fed Proc Am Soc Exp Biol 1988:2:224-236.
11. Nishii Y, Ono M, Fukushima M, Shimizu Y, Niki R, Ohkawa H, Takagaki Y, Okano K, Suda T: Osseous ehanges and abnormalities of mineral metabolism in rats with glvcopeptide-induced nephritis. Endocrinology 1980:107:319-327.
12. Fukushima M, Niki R, Ohkawa H, Shimizu T, Matsunaga I, Nakano H, Takagaki Y, Nishii Y, Okano K, SudaT: Comparative therapeutic effects of vitamin Dj and its derivatives on experimental renal osteodystrophv. Endocrinology 1980:107: 326-333.
13. Shibala S: Nephritogenoside. Tokyo. MYU. 1990.
14. Morii H: Opinionaire survey regarding the treatment of renal osteodystrophy in Japan (with English abstract). Jp J Nephrol 1983;25:89-97.
15. David DS: Mineral and bone homeostasis in renal failure: Pathophysiology and management: in David DS (ed): Calcium Metabolism in Renal Failure and Nephrolithiasis. New York. Wiley. 1977, pp 1-76.
16. Morita A, Tabata T, Inoue T, Nishizawa Y, Morii H: The effect of oral la hydroxycholecalciferol treatment on bone mineral density in hemodialysis patients. Clin Nephrol 1996:46:389-393.
17. Slatopolsky E, Wecrts C, Thielan J, Horst R, Harter H, Martin K: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984:74:2136-2143.
18. Morrison NA, Yeoman R, Kelly PJ, Eisntan JA: Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin. Pro Natl Acad Sci USA 1992:89:6665-6669.
19. Morii H, Miura Y, Nagura Y, Kawaguchi Y, Ogura Y, Imamura N, Shoji R, Tsukamoto Y, Kijinta Y, Suzuki S, Ohki K, Wakasugi M, Inoue T, Hishida A, Ttsuruta YY, Iwamoto N, Nishitani H, Inoue T, Ono T, Fukunaga M, Osawa G: Hexafluoro D3 Research Committee. Japan: Effect of hexafluoro-calcitriol on renal osteodystrophy in hemodialysed patients. Satellite Symp 13th Int Congr Nephrol, Renal Bone Disease. Parathyroid Hormone, and Vitamin D. SevilleJul 1995.
20. Denda M, Finch JF, Brown AJ, Nishii Y, Kubod-cra N, Slatopolsky E: 1.25-Dihydroxyvitamin Di and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996:50:34-39.